Tag: Bharat Biotech

Govt Aims To Vaccinate All Citizens By Year-End, Targets 216 Cr Doses By Dec – Check Rollout Plan

Government panel recommends 12-16 week gap between Covishield doses, no change for Covaxin

50 employees of Bharat Biotech test COVID-19 positive; Joint MD’s tweet sparks concern

Bharat Biotech’s Covaxin gets DCGI nod to conduct clinical trials on children above 2 years

COVID Vaccine: DCGI Approves Phase 2/3 Clinical Trial Of Covaxin In Age Group Of 2 To 18 Yrs

Bharat Biotech to manufacture 2 crore doses of Covaxin at UP’s Bulandshahr plant every month

BJP Clears Air On Centre’s Vaccine Export, Says 84% Doses Sent Abroad Part Of Licensing Liabilities

Disheartening to hear some states complaining about Covaxin supply: Bharat Biotech

Vaccine Shortage: SII To Ramp Up Production To 10 Cr Doses By Aug, Bharat Biotech Promises 7.8 Cr Jabs

Covaxin Centres In Delhi Closed As Bharat Biotech Refused To Supply Vaccines On Centre’s Directive: AAP